# Phase I Cetuximab and Concurrent Radio-chemotherapy

> **NCT00522886** · PHASE1 · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 24 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT00522886
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-07
- **Final completion:** —
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-07-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00522886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00522886, "Phase I Cetuximab and Concurrent Radio-chemotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00522886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*